While dosing is the most significant determinant, other psychological and pharmacological factors also play a critical role. A positive mood before drug intake was strongly linked to elevated ratings ...

The work was led by David E. Olson, director of the Institute for Psychedelics and Neurotherapeutics at the University of California, Davis. Scientists in Olson’s lab and at Delix Therapeutics, a ...

Brian Roth, a psychiatrist and pharmacology researcher at the University of North Carolina, explained that determining if patients are fit for psychedelic therapies to ward away “bad trips” can be a ...